[Problems raised by the use of beta blocking agents in diabetics].
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D003327:Coronary Disease / Q000150:complications; D048909:Diabetes Complications; D003925:Diabetic Angiopathies / Q000188:drug therapy; D004347:Drug Interactions; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D007004:Hypoglycemic Agents / Q000494:pharmacology; D007328:Insulin / Q000378:metabolism; D000078790:Insulin Secretion; D050356:Lipid Metabolism
D000319:Adrenergic beta-Antagonists; D007004:Hypoglycemic Agents; D007328:Insulin
Les problèmes posés par l'utilisation des bêtabloquants chez les diabétiques.